Why the study?
With a growing population of cancer survivors receiving radiation therapy, understanding the mechanisms, manifestations, and management of radiation-induced vascular disease is essential.
This review provides a comprehensive overview of radiation-induced vascular disease, highlighting strategies for prevention, screening, diagnosis, and management in the growing population of cancer survivors.
May guide care for cancer survivors at vascular risk; leaves open dedicated prospective trials to establish best practices.
Since the 1990s, there has been a steady increase in the number of cancer survivors to an estimated 17 million in 2019 in the US alone. Radiation therapy today is applied to a variety of malignancies and over 50% of cancer patients. The effects of ionizing radiation on cardiac structure and function, so-called radiation-induced heart disease (RIHD), have been extensively studied. We review the available published data on the mechanisms and manifestations of RIHD, with a focus on vascular disease, as well as proposed strategies for its prevention, screening, diagnosis, and management.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: